triamterene has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wollenberg, A | 1 |
| Meurer, M | 1 |
| Darken, M | 1 |
| McBurney, EI | 1 |
2 other studies available for triamterene and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
[Thiazide diuretic-induced subacute cutaneous lupus erythematosus].
Topics: Aged; Antibodies, Antinuclear; Complement C3; Drug Combinations; Drug Eruptions; Female; Fluorescent | 1991 |
Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene.
Topics: Aged; Drug Combinations; Humans; Hydrochlorothiazide; Lupus Erythematosus, Cutaneous; Male; Middle A | 1988 |